featured-Reporter

First-person essay: Doing my part to end the pandemic 

I want to particularly encourage the African American community, which has been disproportionately impacted by COVID-19, to step forward, receive this vaccine and spread the word to your families. Let’s put this pandemic behind us in 2021 — together.

Tesha Akins

Vanderbilt University Medical Center begins giving COVID-19 vaccines to front-line caregivers

Vanderbilt University Medical Center began vaccinating its front-line caregivers for COVID-19 on Thursday, Dec. 17.

Challenges, achievements share spotlight in 2020

The year 2020 will forever be defined by the global COVID-19 pandemic, and Vanderbilt University Medical Center’s response to it has been nothing short of stunning.
The entire enterprise — clinical, research and education — began preparing for the pandemic’s impact even before the first cases appeared in Tennessee in March, and that dedicated commitment and unceasing effort did not waver in the long months that followed. But while COVID-19 dominated the news during 2020, there were still many other noteworthy achievements that made headlines during the year.

Ann Richmond, MD, Chi Yan, PhD, Jinming Yang, PhD, and colleagues are studying ways to boost antitumor immunity and reduce tumor growth in breast cancer and melanoma.

Study reveals new strategy for reducing tumor growth, metastasis

A team of Vanderbilt investigators has discovered that blocking a certain signaling pathway boosts antitumor immunity and reduces tumor growth and metastasis in models of breast cancer and melanoma.

The “orange team,” led by Buddy Creech, MD, director of the Vanderbilt Vaccine Research Program, assembles in the old Clinical Research Center space in Medical Center North on the first day of the phase 3 Moderna vaccine study this summer.

Coronavirus ‘crusaders’ spur VUMC research achievements

The development of the vaccines, monoclonal antibodies and antiviral drugs that ultimately will defeat COVID-19 wouldn’t have been possible had it not been for the unflagging and selfless efforts of a global army of research nurses, laboratory personnel, recruiters and other staff.

C. Henrique Serezani, PhD, right, and colleagues, from left, Amondrea Blackman, Nathan Klopfenstein and Júlia Miranda Ribeiro Bazzano are studying the early events of the inflammatory response to infection.

Study details early events of inflammatory response

Vanderbilt University Medical Center investigators have identified a key molecular player in the early events of the inflammatory response to infection. The findings suggest new therapeutic possibilities for enhancing the inflammatory response to protect against pathogens and for blocking inflammation gone awry in diseases like arthritis and atherosclerosis.

1 30 31 32 33 34 161